Clinical Trial Update: Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

View source ↗

Summary

Completed clinical trial evaluating semaglutide's effects on sleep apnea in patients with type 2 diabetes or obesity and comorbid obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Shanghai Fengxian District Central Hospital | Conditions: Sleep Apnea Syndrome (OSAS) | Status: COMPLETED